Literature DB >> 1541815

Effects of intravenous IL-8 administration in nonhuman primates.

K J Van Zee1, E Fischer, A S Hawes, C A Hébert, T G Terrell, J B Baker, S F Lowry, L L Moldawer.   

Abstract

IL-8, a cytokine known for its potent and specific neutrophil activation and chemoattractant properties, has been recently detected in the circulation during septic shock, endotoxemia, and after IL-1 alpha administration. Because of its observed in vitro actions, it has been hypothesized that IL-8 may contribute to the dynamics of circulating granulocytes and to the pathologic sequelae seen in sepsis. Here, human rIL-8 is administered to healthy nonhuman primates as a single i.v. injection or as a continuous 8-h i.v. infusion. We demonstrate that both methods of i.v. administration result in a rapid but transient, severe granulocytopenia, followed by a granulocytosis that persists as long as IL-8 levels are detectable in the circulation. There were no hemodynamic changes after IL-8 administration, and animals remained clinically stable during the 24-h observation period. No detectable circulating TNF-alpha, IL-1 beta, or IL-6 response was induced by either IL-8 administration regimen. Histopathologic examination revealed mild to moderate neutrophilic margination in lung, liver, and spleen, of greater severity in baboons receiving the 8-h infusion. There was no associated neutrophilic infiltration or tissue injury. Thus, IL-8 modulates circulating granulocyte dynamics and likely directs their actions, but when administered i.v. to healthy animals, either as a bolus dose or as a continuous infusion for up to 8 h, does not induce the hemodynamic and metabolic aberrations or the acute organ damage seen during sepsis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1541815

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Phenotypic knockout of HIV type 1 chemokine coreceptor CCR-5 by intrakines as potential therapeutic approach for HIV-1 infection.

Authors:  A G Yang; X Bai; X F Huang; C Yao; S Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 2.  Chemokines and tissue injury.

Authors:  M B Furie; G J Randolph
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

Review 3.  Novel aspects of inflammation: interleukin-8 and related chemotactic cytokines.

Authors:  M Baggiolini
Journal:  Clin Investig       Date:  1993-10

4.  CXC chemokines, MIP-2 and KC, induce P-selectin-dependent neutrophil rolling and extravascular migration in vivo.

Authors:  X W Zhang; Q Liu; Y Wang; H Thorlacius
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

5.  Serum concentrations and peripheral secretion of the beta chemokines monocyte chemoattractant protein 1 and macrophage inflammatory protein 1alpha in alcoholic liver disease.

Authors:  N C Fisher; D A Neil; A Williams; D H Adams
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

6.  Acute lung injury after aortic surgery: the relation between lung and leg microvascular permeability to 111indium-labelled transferrin and circulating mediators.

Authors:  P G Raijmakers; A B Groeneveld; J A Rauwerda; G J Teule; C E Hack
Journal:  Thorax       Date:  1997-10       Impact factor: 9.139

7.  High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome.

Authors:  S Chollet-Martin; P Montravers; C Gibert; C Elbim; J M Desmonts; J Y Fagon; M A Gougerot-Pocidalo
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

8.  Interleukin-8 and the neutrophil response to mucosal gram-negative infection.

Authors:  W W Agace; S R Hedges; M Ceska; C Svanborg
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

9.  A locked, dimeric CXCL12 variant effectively inhibits pulmonary metastasis of CXCR4-expressing melanoma cells due to enhanced serum stability.

Authors:  Tomonori Takekoshi; Joshua J Ziarek; Brian F Volkman; Sam T Hwang
Journal:  Mol Cancer Ther       Date:  2012-08-06       Impact factor: 6.261

10.  In vitro and in vivo effects of leukotriene B4 antagonism in a primate model of asthma.

Authors:  C R Turner; R Breslow; M J Conklyn; C J Andresen; D K Patterson; A Lopez-Anaya; B Owens; P Lee; J W Watson; H J Showell
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.